Skip to main content
Home

Breadcrumb

  1. Home
  2. News
  3. Search results
Displaying results 576 - 600 of 673 Clear search
Zyme Communications
10 Nov 2021

Insightful Science acquires LabArchives to expand its electronic lab notebook and LIMS solutions for scientific discovery

San Diego, CA, 10th November 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire LabArchives.

Zyme Communications
10 Nov 2021

FUJIFILM Irvine Scientific expands its Armstrong R&D Cell Culture Center of Excellence to accelerate new product development

SANTA ANA, California, November 10, 2021: FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, today announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California. This expansion marks an ongoing commitment to the advancement of discovery research, bioproduction, cell and gene therapy,…

Zyme Communications
02 Nov 2021

BioNet and Sartorius’ company BIA Separations collaborate on production process development of mRNA vaccines

Ajdovšcina, Slovenia & Bangkok, Thailand, 02 November 2021: BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, today announced the successful development of an optimized mRNA manufacturing process.

Zyme Communications
21 Oct 2021

Bio-Rad launches its CFX Opus Dx real-time PCR detection systems for in vitro diagnostics

HERCULES, Calif.––Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System, real-time PCR detection systems that have been listed with the US Food and Drug Administration (FDA) for IVD testing and that meet the CE-IVD requirement for IVD use in…

Zyme Communications
18 Oct 2021

H.E.L Group releases latest update to labCONSOL automation software with enhanced calibration and process safety functionality

London, UK, 18 October 2021: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced the release of the latest version of its laboratory automation software, labCONSOL™ 1.2. The new functionality included in the update further enhances the intuitive user experience to increase lab productivity and…

Zyme Communications
12 Oct 2021

Dotmatics partners with RockStep Solutions to provide an integrated solution for digitalized in vivo drug discovery

Bishop’s Stortford, UK, and Portland, ME, USA, 12 October 2021: Dotmatics Ltd, an Insightful Science company that provides leading-edge scientific informatics software to drive the automation of lab data workflows and accelerate critical R&D discovery, today announced a partnership with RockStep Solutions (RockStep), a developer of software tools for managing data and operations for in vivo…

Zyme Communications
05 Oct 2021

seqWell appoints new commercial team, led by Chief Commercial Officer Steve Smith

Beverly MA, US, 05 October 2021: seqWell, a global provider of next-generation sequencing (NGS) library technologies based on its proprietary plexWell™ multiplexing platform, today announced five appointments to its commercial team.

Zyme Communications
04 Oct 2021

CrestOptics introduces DeepSIM super resolution confocal microscope module

Rome, IT, 04 October 2021: CrestOptics SpA, a manufacturer of high-end microscopy solutions and advanced systems for fluorescence microscopy and diagnostic applications, today announced the launch of DeepSIM, a super resolution module designed to enhance the imaging capabilities of confocal microscope systems. The DeepSIM module can be used with Crest’s X-light V3 spinning disk, or alternative…

Zyme Communications
30 Sep 2021

Bio-Rad launches IgA and IgM SARS-CoV-2 Bio-Plex pro immunoassay panels to study COVID-19 antibody response

HERCULES, Calif.–September 30, 2021: Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex™ Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens. The panels are for research use only (RUO).

Zyme Communications
30 Sep 2021

Gyros Protein Technologies introduces Gyrolab AAV9 Titer Kit to support AAV-based cell and gene therapy production

Uppsala, Sweden, 30 September 2021: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and a leading provider of peptide synthesizers and reagents, today announced the introduction of Gyrolab® AAV9 Titer Kit for rapid determination of physical titer in adeno-associated virus serotype 9 (AAV9) vector-based cell and gene therapy manufacturing.

Zyme Communications
29 Sep 2021

Avacta announces achievement of pre-clinical development milestone in LG Chem Life Sciences partnership

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce that a pre-clinical development milestone has been achieved in the multi-target therapeutics development partnership with LG Chem Life Sciences, the life sciences division of the…

Zyme Communications
29 Sep 2021

FUJIFILM Irvine Scientific begins customer qualification of European manufacturing facility

SANTA ANA, California: FUJIFILM Irvine Scientific, Inc. today announced that it completed construction and started the commissioning phase of its new manufacturing facility in Tilburg, the Netherlands. The commissioning milestone marks the beginning of validating the facility and equipment in anticipation of full operations starting in late 2021. The new facility will join manufacturing locations…

Zyme Communications
21 Sep 2021

ELRIG UK launches equality, diversity, and inclusion guiding principles at Drug Discovery 2021

York, UK:  The European Laboratory Research & Innovation Group (ELRIG) UK today announced it will launch its equality, diversity, and inclusion (EDI) guiding principles at Drug Discovery 2021. The principles were developed with the support of Equality, Diversity and Inclusion in Science and Health (EDIS), a coalition of organisations working to improve EDI within the science and health…

Zyme Communications
21 Sep 2021

Dotmatics appoints Mike McKee as new president to lead the industry transformation to data-driven scientific research

Highly accomplished technology CEO appointed to accelerate the company’s immense scale and capitalise on unprecedented momentum.

Zyme Communications
21 Sep 2021

Optibrium appoints Professor Andy Black as non-executive Chair

Optibrium™, a developer of software for drug discovery, today announced the appointment of Professor Andy Black as non-executive Chair of its Board of Directors. Following the company’s recent investment from Kester Capital, the appointment will help to continue Optibrium’s strong commercial growth calling on Andy’s extensive experience in leading strategic expansion. This will include the…

Zyme Communications
17 Sep 2021

FairJourney Biologics announces THE ANTIBODY SERIES 2022

Porto, Portugal –FairJourney Biologics SA, leader in the discovery and optimisation of antibodies, today announced, after the overwhelming success of the 2021 ANTIBODY SERIES conference, planning for a larger scale 2022 ANTIBODY SERIES is underway.

Zyme Communications
15 Sep 2021

GammaDelta Therapeutics initiates first-in-human Phase 1 trial of GDX012 for treatment of acute myeloid leukaemia

London, UK, 15 Sept 2021: GammaDelta Therapeutics Ltd. (GDT), a biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for cancer, today announced that it has initiated a first-in-human Phase I clinical trial evaluating GDX012 for the treatment of acute myeloid leukaemia (AML). GDX012 is an allogeneic, non-engineered, variable delta 1 (Vδ1) gamma…

Zyme Communications
14 Sep 2021

Insightful Science acquires FCS Express, strengthening its leadership position as the Cloud for Scientific Discovery

Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire De Novo Software, the maker of FCS Express™. FCS Express is the fastest-growing flow cytometry data analysis solution in the industry.

Zyme Communications
10 Sep 2021

Optibrium releases 3D ligand-based design module for StarDrop drug discovery software

Optibrium Ltd, a developer of software for drug discovery,  has announced the release of the latest version of StarDrop™, its comprehensive software platform for small molecule design, optimisation and data analysis. StarDrop is used by more than 160 organisations worldwide, including many of the top global pharmaceutical companies. The release of StarDrop 7.1 further expands the platform’s…

Zyme Communications
06 Sep 2021

Avacta announces new appointments to the Scientific Advisory Board of its Therapeutics Division

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces new appointments to its Scientific Advisory Board (SAB), reflecting the progress of the Therapeutics Division and Avacta’s transition to a clinical stage Company.

Zyme Communications
03 Sep 2021

Avacta appoints Dr Fiona McLaughlin as Chief Scientific Officer of its Therapeutics Division

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces the appointment of Dr Fiona McLaughlin as Chief Scientific Officer of its Therapeutics Division effective immediately.

Zyme Communications
01 Sep 2021

FairJourney Biologics expands into new facilities in Porto, Portugal

FairJourney Biologics SA (FJB), leader in the discovery and optimisation of antibodies, announced it has relocated into a larger, newly purpose-built research center in Porto, Portugal. The new premises support the Company’s expansion and plans for further growth.

Zyme Communications
20 Aug 2021

Avacta appoints Dr. Mark Goldberg as Non-Executive Director

Avacta Group plc (AIM: AVCT), a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative Affimer® and pre|CISION™ platforms, announces the appointment of Dr Mark Goldberg as Non-executive Director to the Board with immediate effect.

Zyme Communications
19 Aug 2021

ELRIG UK announces Drug Discovery 2021 event to host SLAS’s Innovation AveNEW

The European Laboratory Research & Innovation Group (ELRIG) UK has announced the programme details for Drug Discovery 2021, which will take place at the Exhibition Centre ACC in Liverpool, UK, from 19–20 October.

Zyme Communications
17 Aug 2021

ERS Genomics and Cellular Engineering Technologies enter CRISPR/Cas9 license agreement

License allows Cellular Engineering Technologies to develop, manufacture and commercialize next generation stem cell lines using CRISPR/Cas9 technology

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 22
  • Page 23
  • Current page 24
  • Page 25
  • Page 26
  • …
  • Next page ›
  • Last page »
Receive our newsletter

Cambridge Network Limited is a company registered in England under company No. 3400152

The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

Email: [email protected], Tel: 01223 746801

© 2026 Cambridge Network. All Rights Reserved.

Website by KISS